Published in Clin Microbiol Infect on July 01, 2002
Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev (2007) 15.66
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol (2004) 4.51
Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol (2004) 4.03
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol (2005) 3.41
Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis (2004) 3.22
Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol (2006) 2.60
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol (2005) 2.18
Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J Clin Microbiol (2004) 2.06
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol (2007) 1.99
Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol (2006) 1.81
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One (2011) 1.73
Candidemia in Finland, 1995-1999. Emerg Infect Dis (2003) 1.55
Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS One (2013) 1.44
Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence (2013) 1.32
Retracted Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain. J Clin Microbiol (2010) 1.16
Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol (2013) 1.10
Candida guilliermondii fungemia in patients with hematologic malignancies. J Clin Microbiol (2006) 1.05
Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Eur J Clin Microbiol Infect Dis (2003) 1.01
Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis (2007) 0.91
Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai. BMC Infect Dis (2014) 0.87
In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method. ScientificWorldJournal (2013) 0.85
Candida species distribution in bloodstream cultures in Lyon, France, 1998-2001. Eur J Clin Microbiol Infect Dis (2005) 0.83
Host response to Candida albicans bloodstream infection and sepsis. Virulence (2015) 0.82
Visual analysis of DNA microarray data for accurate molecular identification of non-albicans Candida isolates from patients with candidemia episodes. J Clin Microbiol (2013) 0.79
A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell (2000) 5.53
HIV-1 reverse transcription. A termination step at the center of the genome. J Mol Biol (1994) 4.15
Random amplified polymorphic DNA assay is less discriminant than pulsed-field gel electrophoresis for typing strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1993) 3.21
Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob Agents Chemother (1987) 2.80
Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa. Arch Dis Child (2000) 2.48
Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis (2001) 2.48
Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J Clin Microbiol (1999) 2.12
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol (1998) 2.11
High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis (2009) 2.06
Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol (1988) 2.00
Multiple scattering in a reflecting cavity: application to fish counting in a tank. J Acoust Soc Am (2001) 1.93
Effect of erythromycin on microbial antagonisms: a study in gnotobiotic mice associated with a human fecal flora. J Infect Dis (1983) 1.90
Plasmid-mediated high-level resistance to erythromycin in Escherichia coli. Antimicrob Agents Chemother (1986) 1.72
Inducible transfer of conjugative transposon Tn1545 from Enterococcus faecalis to Listeria monocytogenes in the digestive tracts of gnotobiotic mice. Antimicrob Agents Chemother (1991) 1.68
RhoG GTPase controls a pathway that independently activates Rac1 and Cdc42Hs. Mol Biol Cell (1998) 1.66
The mitochondrial ADP/ATP carrier: structural, physiological and pathological aspects. Biochimie (1998) 1.62
Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol (1990) 1.56
Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis (1991) 1.51
Biodiversity of Pneumocystis carinii hominis: typing with different DNA regions. J Clin Microbiol (1997) 1.49
Reduction of the aerobic Gram negative bacterial flora of the gastro-intestinal tract and prevention of traveller's diarrhea using oral erythromycin. Ann Microbiol (Paris) (1982) 1.48
Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents (2000) 1.48
Prevalence of virulence genes and clonality in Escherichia coli strains that cause bacteremia in cancer patients. Infect Immun (2000) 1.47
Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol (1998) 1.42
Comparison of ribotyping, pulsed-field gel electrophoresis and random amplified polymorphic DNA for typing Clostridium difficile strains. FEMS Microbiol Lett (1994) 1.40
Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. Mol Biol Cell (2000) 1.39
Cost effectiveness of the induced sputum technique for the diagnosis of Pneumocystis carinii pneumonia (PCP) in HIV-infected patients. Eur Respir J (1993) 1.37
Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Mol Cell Biol (2001) 1.35
Random amplified polymorphic DNA typing versus pulsed-field gel electrophoresis for epidemiological typing of vancomycin-resistant enterococci. J Clin Microbiol (1996) 1.35
Decontamination of polymerase chain reaction reagents for detection of low concentrations of 16S rRNA genes. Mol Biotechnol (1997) 1.34
The proseal laryngeal mask: results of a descriptive trial with experience of 300 cases. Br J Anaesth (2002) 1.32
Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora. Antimicrob Agents Chemother (1986) 1.31
Epidemiology of intestinal colonization by members of the family Enterobacteriaceae highly resistant to erythromycin in a hematology-oncology unit. Antimicrob Agents Chemother (1986) 1.30
Neurogenic tumors of the stomach. Report of 18 cases and review of the literature. Rofo (1983) 1.22
Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies. J Clin Microbiol (1992) 1.20
Detection of genes in feces by booster polymerase chain reaction. J Clin Microbiol (1992) 1.20
Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis (1995) 1.20
A role for cofilin and LIM kinase in Listeria-induced phagocytosis. J Cell Biol (2001) 1.19
Plasmid-mediated susceptibility to intestinal microbial antagonisms in Escherichia coli. Infect Immun (1985) 1.19
Metastases of the digestive tract. Report of 77 cases and review of the literature. Eur J Radiol (1983) 1.19
Ear, nose, and throat cancer: ultrasound diagnosis of metastasis to cervical lymph nodes. Radiology (1984) 1.19
Differential effect of Rac and Cdc42 on p38 kinase activity and cell cycle progression of nonadherent primary mouse fibroblasts. J Biol Chem (2000) 1.16
Study of internal transcribed spacer and mitochondrial large-subunit genes of Pneumocystis carinii hominis isolated by repeated bronchoalveolar lavage from human immunodeficiency virus-infected patients during one or several episodes of pneumonia. J Clin Microbiol (1997) 1.15
Pseudoepidemic of aspergillosis after development of pulmonary infiltrates in a group of bone marrow transplant patients. J Clin Microbiol (1987) 1.14
The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker. J Gen Virol (1992) 1.14
Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital. J Hosp Infect (2007) 1.11
Preliminary results of Pneumocystis carinii strain differentiation by using molecular biology. J Clin Microbiol (1994) 1.11
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J Infect Dis (1994) 1.11
Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water. Infect Immun (2001) 1.11
Molecular architecture of the ER translocase probed by chemical crosslinking of Sss1p to complementary fragments of Sec61p. EMBO J (1997) 1.11
Simultaneous determination of pyrimidine or purine deoxyribonucleoside triphosphates using a polymerase assay. Anal Biochem (1999) 1.09
Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles. Antimicrob Agents Chemother (1989) 1.08
Effect of oral ofloxacin on fecal bacteria in human volunteers. Antimicrob Agents Chemother (1987) 1.07
Effectiveness of simple measures to control an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections in an intensive care unit. Infect Control Hosp Epidemiol (1990) 1.07
AUUUA motifs are dispensable for rapid degradation of the mouse c-myc RNA. Oncogene (1990) 1.07
Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients. J Natl Cancer Inst (1996) 1.06
Characterization of AfaE adhesins produced by extraintestinal and intestinal human Escherichia coli isolates: PCR assays for detection of Afa adhesins that do or do not recognize Dr blood group antigens. J Clin Microbiol (2001) 1.06
Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. Am Rev Respir Dis (1993) 1.04
AIDS-related Pneumocystis carinii pneumonia in the era of adjunctive steroids: implication of BAL neutrophilia. Am J Respir Crit Care Med (1999) 1.03
Conjugal transfer of plasmid DNA from Enterococcus faecalis to Escherichia coli in digestive tracts of gnotobiotic mice. Antimicrob Agents Chemother (1992) 1.01
Genesis of a KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain. Euro Surveill (2010) 1.01
Differential sensitivity of FOS and JUN family members to calpains. Oncogene (1994) 1.00
Trichoderma pseudokoningii as a cause of fatal infection in a bone marrow transplant recipient. Clin Infect Dis (1995) 1.00
Comparative translocation of enteropathogenic Campylobacter spp. and Escherichia coli from the intestinal tract of gnotobiotic mice. Infect Immun (1987) 0.99
Use of beta-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization. J Infect Dis (1989) 0.99
BCG vaccination in South African HIV-exposed infants--risks and benefits. S Afr Med J (2009) 0.99
Identification of Pneumocystis carinii f. sp. hominis gene sequences in filtered air in hospital environments. J Clin Microbiol (1998) 0.98
Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells. Cell Death Differ (2006) 0.97
Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit. Eur J Clin Microbiol Infect Dis (1995) 0.97
Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice. Antimicrob Agents Chemother (1988) 0.97
Pneumocystis carinii hominis sequencing to study hypothetical person-to-person transmission. AIDS (1997) 0.95
Ultrasound evaluation of common bile duct size in normal adult patients and following cholecystectomy. A report of 750 cases. Eur J Radiol (1981) 0.95
Heterogeneity of genes conferring high-level resistance to erythromycin by inactivation in enterobacteria. Ann Inst Pasteur Microbiol (1988) 0.95
Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharm Res (1991) 0.95
DNA curvature controls termination of plus strand DNA synthesis at the centre of HIV-1 genome. J Mol Biol (1997) 0.94
Fungal peritonitis in patients on peritoneal dialysis. Am J Nephrol (1994) 0.94
Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis. AIDS (1992) 0.94
Toxoplasma gondii pneumonia in patients with the acquired immunodeficiency syndrome. Am J Med (1990) 0.94
Osteoarthritis caused by Neocosmospora vasinfecta. Med Mycol (1999) 0.94
Use of the polymerase chain reaction technique on induced-sputum samples for the diagnosis of Pneumocystis carinii pneumonia in HIV-infected patients. A clinical and cost-analysis study. Am J Clin Pathol (1995) 0.93
Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit. Antimicrob Agents Chemother (1986) 0.93
Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival. Int J Tuberc Lung Dis (2011) 0.93
Increased apoptosis, changes in intracellular Ca2+, and functional alterations in lymphocytes and macrophages after in vitro exposure to static magnetic field. J Toxicol Environ Health A (1998) 0.93
Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers. J Antimicrob Chemother (1990) 0.92
Hand contamination before and after different hand hygiene techniques: a randomized clinical trial. J Hosp Infect (2002) 0.91
Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo. Antimicrob Agents Chemother (1992) 0.91
Ultrasonography of hepatic cavernous haemangiomas. Br J Radiol (1983) 0.91
Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards. Eur J Clin Microbiol Infect Dis (2011) 0.91
Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice. Antimicrob Agents Chemother (1991) 0.90
Development of ciprofloxacin-loaded nanoparticles: physicochemical study of the drug carrier. J Control Release (1998) 0.88
Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. Euro Surveill (2014) 0.88
Kinetic studies on promoter-RNA polymerase complexes. Methods Enzymol (1991) 0.87
In vivo activity of nifurzide and nifuroxazide in intestinal bacteria in man and gnotobiotic mice. J Appl Bacteriol (1985) 0.87
Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high-dose chemotherapy. Bone Marrow Transplant (1991) 0.87
Shedding of antibiotic-resistant members of the family Enterobacteriaceae in healthy residents of France and Jordan. Res Microbiol (1995) 0.87
Single-step polymerase chain reaction for combined gene detection and epidemiological typing in three bacterial models. FEMS Microbiol Lett (1997) 0.87
Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients. Intensive Care Med (1993) 0.87
Pneumocystis jirovecii dihydropteroate synthase genotypes in French patients with pneumocystosis: a 1998-2001 prospective study. Med Mycol (2003) 0.87
In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study. Clin Microbiol Infect (2003) 0.86
Linking Pneumocystis jiroveci sulfamethoxazole resistance to the alleles of the DHPS gene using functional complementation in Saccharomyces cerevisiae. Clin Microbiol Infect (2009) 0.86
Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647). Antimicrob Agents Chemother (2001) 0.86